ClinicalTrials.Veeva

Menu

Unexpected ABR Results in Patients Suspected With Auditory Neuropathy Spectrum Disorder

M

Medipol Health Group

Status

Completed

Conditions

Auditory Neuropathy

Treatments

Diagnostic Test: Hearing Thresholds Assessments

Study type

Interventional

Funder types

Other

Identifiers

NCT06125015
E-10840098-772.02-3627

Details and patient eligibility

About

This study aimed to assess the clinical evaluations and potential underlying pathologies in patients diagnosed with Auditory Neuropathy Spectrum Disorder (ANSD) who exhibited unusual results in audiological tests. The research involved the retrospective analysis of audiological tests of 11 patients conducted by expert audiologists at Istanbul Medipol Mega Hospital between 2010 and 2020. These patients displayed abnormalities in their Auditory Brainstem Response (ABR) tests. The study sought to investigate patients with ANSD who presented atypical audiological findings, shedding light on the associated clinical aspects and potential causes of such anomalies.

Enrollment

11 patients

Sex

All

Ages

Under 46 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of wave V with cochlear microphonics

Exclusion criteria

  • Type B tympanogram

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems